55 results
Page 3 of 3
F-1
fevjysg agn7hj
8 Mar 21
Registration statement (foreign)
9:50pm
6-K
EX-99.1
zdy2cj3r
16 Nov 20
Silence Therapeutics Presents Positive Pre-Clinical Data for SLN360 for the Treatment of Elevated Lipoprotein(a) at American Heart Association 2020
7:00am
6-K
EX-99.1
2byl tdk35sf
2 Nov 20
Silence Therapeutics Appoints Dr. Marie Wikström Lindholm to its
7:31am
POS AM
xjc24jhqjgsm3ssuzrb
23 Sep 20
Prospectus update (post-effective amendment)
4:47pm
6-K
EX-99.1
h4iweobp
14 Sep 20
Silence Therapeutics Appoints Mark Rothera as President and Chief Executive Officer
7:10am
6-K
EX-99.2
78060k4t9q rj4f
14 Sep 20
Silence Therapeutics Appoints Mark Rothera as President and Chief Executive Officer
7:10am
S-8
vyfg4v5otnc3 uitt
9 Sep 20
Registration of securities for employees
2:36pm
6-K
EX-99.1
71isa4h210hqo576
8 Sep 20
Silence Therapeutics Provides Research and Development Update
7:35am
424B4
vdcxqpxazkx5wz
8 Sep 20
Prospectus supplement with pricing info
7:31am
F-1/A
1hyk hqz5u4
26 Aug 20
Registration statement (foreign) (amended)
3:03pm
F-1
z4vuxqgsi
20 Aug 20
Registration statement (foreign)
4:50pm
F-1
EX-10.6
z256v7riemuabloy
20 Aug 20
Registration statement (foreign)
4:50pm
DRS/A
dukrs
31 Jul 20
Draft registration statement (amended)
12:00am
DRS
EX-10
w9gi99 xbalpa9zdv
22 Jun 20
Draft registration statement
12:00am
DRS
8sptxks
22 Jun 20
Draft registration statement
12:00am